Short answers, pulled from the story.
Cencora was formed in 2001 as AmerisourceBergen, through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. The company changed its name to Cencora on the 30th of August 2023 and began trading on the New York Stock Exchange under the ticker symbol COR.
Cencora handles approximately 20 percent of all pharmaceuticals sold and distributed throughout the United States. The company ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
In June 2020, the U.S. Department of Health and Human Services named AmerisourceBergen as the company responsible for allocating shipments of remdesivir vials to American hospitals, working alongside HHS and state governments. The arrangement covered projected output of more than 500,000 treatment courses through the end of September 2020.
AmerisourceBergen was part of a $26 billion settlement reached in January 2022 with McKesson, Cardinal Health, and Johnson & Johnson, covering 46 states, Washington DC, and roughly 90 percent of municipal governments. The company had also previously agreed to pay $260 million to two Ohio counties as part of an earlier resolution.
Between 2001 and 2014, an AmerisourceBergen subsidiary in Alabama ran a program that pooled drug product from multiple vials into untested containers and repackaged it into pre-filled syringes lacking FDA approval, generating at least $99.6 million in profit over 13 years. The company settled civil fraud allegations in October 2018 for a combined total of $885 million.
Good Neighbor Pharmacy is a retailers' cooperative network of more than 3,400 independently owned and operated pharmacies in the United States. AmerisourceBergen sponsors the network and owns the Good Neighbor Pharmacy name, and it runs an annual trade show called ThoughtSpot held in both Orlando and Las Vegas.